CN106769350B - 一种用于富含脂滴组织快速完全透明化的方法 - Google Patents
一种用于富含脂滴组织快速完全透明化的方法 Download PDFInfo
- Publication number
- CN106769350B CN106769350B CN201710049563.3A CN201710049563A CN106769350B CN 106769350 B CN106769350 B CN 106769350B CN 201710049563 A CN201710049563 A CN 201710049563A CN 106769350 B CN106769350 B CN 106769350B
- Authority
- CN
- China
- Prior art keywords
- transparence
- tissue
- sample
- rich
- fat drips
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- 230000008569 process Effects 0.000 claims abstract description 11
- 239000000017 hydrogel Substances 0.000 claims abstract description 5
- 238000012805 post-processing Methods 0.000 claims abstract description 5
- 210000001519 tissue Anatomy 0.000 claims description 60
- 210000004185 liver Anatomy 0.000 claims description 43
- 102000004882 Lipase Human genes 0.000 claims description 28
- 108090001060 Lipase Proteins 0.000 claims description 28
- 239000004367 Lipase Substances 0.000 claims description 27
- 235000019421 lipase Nutrition 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 13
- 230000008520 organization Effects 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 238000005562 fading Methods 0.000 claims description 8
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000004380 Cholic acid Substances 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 6
- 229960002471 cholic acid Drugs 0.000 claims description 6
- 235000019416 cholic acid Nutrition 0.000 claims description 6
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 6
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 4
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000004043 dyeing Methods 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 claims description 4
- BHTRKEVKTKCXOH-UHFFFAOYSA-N Taurochenodesoxycholsaeure Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)CC2 BHTRKEVKTKCXOH-UHFFFAOYSA-N 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 210000000577 adipose tissue Anatomy 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- BHTRKEVKTKCXOH-LBSADWJPSA-N tauroursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)CC1 BHTRKEVKTKCXOH-LBSADWJPSA-N 0.000 claims description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 239000003613 bile acid Substances 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000013504 Triton X-100 Substances 0.000 claims 1
- 229920004890 Triton X-100 Polymers 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 210000000232 gallbladder Anatomy 0.000 claims 1
- 230000003287 optical effect Effects 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 24
- 229940040461 lipase Drugs 0.000 description 24
- 229910052938 sodium sulfate Inorganic materials 0.000 description 24
- 235000011152 sodium sulphate Nutrition 0.000 description 24
- 239000000243 solution Substances 0.000 description 17
- 238000003384 imaging method Methods 0.000 description 14
- 238000012545 processing Methods 0.000 description 12
- 239000000975 dye Substances 0.000 description 10
- 230000001079 digestive effect Effects 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000005238 degreasing Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- QURLONWWPWCPIC-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanol;3,6-dichloro-2-methoxybenzoic acid Chemical compound NCCOCCO.COC1=C(Cl)C=CC(Cl)=C1C(O)=O QURLONWWPWCPIC-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- -1 sterol ester Chemical class 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 108010014765 tomato lectin Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
Abstract
Description
Claims (16)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710049563.3A CN106769350B (zh) | 2017-01-20 | 2017-01-20 | 一种用于富含脂滴组织快速完全透明化的方法 |
PCT/CN2018/073471 WO2018133847A1 (zh) | 2017-01-20 | 2018-01-19 | 一种用于富含脂滴组织快速完全透明化的方法 |
US16/479,874 US11415494B2 (en) | 2017-01-20 | 2018-01-19 | Method of rapidly and completely rendering lipid-droplet-rich tissue transparent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710049563.3A CN106769350B (zh) | 2017-01-20 | 2017-01-20 | 一种用于富含脂滴组织快速完全透明化的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106769350A CN106769350A (zh) | 2017-05-31 |
CN106769350B true CN106769350B (zh) | 2019-11-22 |
Family
ID=58942119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710049563.3A Active CN106769350B (zh) | 2017-01-20 | 2017-01-20 | 一种用于富含脂滴组织快速完全透明化的方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11415494B2 (zh) |
CN (1) | CN106769350B (zh) |
WO (1) | WO2018133847A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106769350B (zh) | 2017-01-20 | 2019-11-22 | 上海交通大学 | 一种用于富含脂滴组织快速完全透明化的方法 |
CN107727463B (zh) * | 2017-09-18 | 2021-01-22 | 南方医科大学珠江医院 | 超厚组织切片的制备及细胞水平再现组织三维形态结构的方法 |
CN108956242A (zh) * | 2018-05-16 | 2018-12-07 | 绍兴文理学院 | 一种乳腺癌腋窝淋巴结离体组织标本的固定处理方法 |
CN108918235A (zh) * | 2018-05-16 | 2018-11-30 | 绍兴文理学院 | 一种肿瘤淋巴结离体标本的固定处理方法 |
CN108918234A (zh) * | 2018-05-16 | 2018-11-30 | 绍兴文理学院 | 一种乳腺癌腋窝淋巴结清扫组织标本的处理方法 |
CN110068559B (zh) * | 2019-04-08 | 2020-08-18 | 华中科技大学 | 一种生物组织透明化成像方法 |
CN113781848B (zh) * | 2021-08-14 | 2023-03-07 | 西安电子科技大学 | 一种基于智能手机的光学投影断层成像装置、系统及方法 |
CN115728101A (zh) * | 2021-09-01 | 2023-03-03 | 西湖大学 | 一种生物组织透明膨胀方法和成像方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552981A (zh) * | 2012-01-18 | 2012-07-11 | 北京申佑生物科技有限公司 | 一种组织工程骨/软骨一体支架的制备方法 |
CN103492852A (zh) * | 2011-04-28 | 2014-01-01 | 独立行政法人理化学研究所 | 生物材料的透明化方法、及其利用 |
CN104350372A (zh) * | 2012-08-09 | 2015-02-11 | 斯坦福大学托管董事会 | 用于制备供显微镜分析的生物样本的方法和组合物 |
CN106323708A (zh) * | 2016-07-29 | 2017-01-11 | 浙江大学 | 一种透明化试剂、生物组织透明化成像方法及其应用 |
US11379508B1 (en) * | 2019-02-22 | 2022-07-05 | Splunk Inc. | User interface with automated condensation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060188892A1 (en) * | 2005-02-18 | 2006-08-24 | Ambion, Inc. | Enzymatic digestion of tissue |
US7666620B2 (en) | 2006-11-08 | 2010-02-23 | Richard-Allan Scientific Company | Rapid tissue processing system |
EP2926658B1 (en) * | 2012-10-30 | 2018-08-29 | Kanazawa Medical University | Kit for producing transparentized biological specimen, and method for producing transparentized biological specimen |
CN104155160A (zh) * | 2014-08-12 | 2014-11-19 | 陆可望 | 一种不含苯的组织脱蜡透明剂 |
WO2016073941A1 (en) * | 2014-11-07 | 2016-05-12 | California Institute Of Technology | Methods for phenotyping of intact bones by tissue clearing and staining |
CN106769350B (zh) | 2017-01-20 | 2019-11-22 | 上海交通大学 | 一种用于富含脂滴组织快速完全透明化的方法 |
-
2017
- 2017-01-20 CN CN201710049563.3A patent/CN106769350B/zh active Active
-
2018
- 2018-01-19 US US16/479,874 patent/US11415494B2/en active Active
- 2018-01-19 WO PCT/CN2018/073471 patent/WO2018133847A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103492852A (zh) * | 2011-04-28 | 2014-01-01 | 独立行政法人理化学研究所 | 生物材料的透明化方法、及其利用 |
CN102552981A (zh) * | 2012-01-18 | 2012-07-11 | 北京申佑生物科技有限公司 | 一种组织工程骨/软骨一体支架的制备方法 |
CN104350372A (zh) * | 2012-08-09 | 2015-02-11 | 斯坦福大学托管董事会 | 用于制备供显微镜分析的生物样本的方法和组合物 |
CN106323708A (zh) * | 2016-07-29 | 2017-01-11 | 浙江大学 | 一种透明化试剂、生物组织透明化成像方法及其应用 |
US11379508B1 (en) * | 2019-02-22 | 2022-07-05 | Splunk Inc. | User interface with automated condensation |
Also Published As
Publication number | Publication date |
---|---|
US11415494B2 (en) | 2022-08-16 |
WO2018133847A1 (zh) | 2018-07-26 |
CN106769350A (zh) | 2017-05-31 |
US20210072124A1 (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106769350B (zh) | 一种用于富含脂滴组织快速完全透明化的方法 | |
Pawlina et al. | Histology: a text and atlas: with correlated cell and molecular biology | |
Kolesová et al. | Comparison of different tissue clearing methods and 3D imaging techniques for visualization of GFP-expressing mouse embryos and embryonic hearts | |
Chen et al. | UbasM: An effective balanced optical clearing method for intact biomedical imaging | |
CN107209093B (zh) | 生物材料用透明化试剂、体系及其利用 | |
Ding et al. | Multiscale light-sheet for rapid imaging of cardiopulmonary system | |
Vieites-Prado et al. | Tissue clearing and 3D imaging in developmental biology | |
Gonzalez-Bellido et al. | Labeling and confocal imaging of neurons in thick invertebrate tissue samples | |
Liu et al. | Three-dimensional, isotropic imaging of mouse brain using multi-view deconvolution light sheet microscopy | |
CN110068559B (zh) | 一种生物组织透明化成像方法 | |
Cai et al. | Whole-mouse clearing and imaging at the cellular level with vDISCO | |
Sands et al. | It's clearly the heart! Optical transparency, cardiac tissue imaging, and computer modelling | |
Farkas | Invention and commercialization in optical bioimaging | |
JP2003066035A (ja) | 水溶性組織清澄溶液 | |
CN108106909B (zh) | 一种生物组织光透明剂、光透明化方法及其应用 | |
Ke et al. | Optical clearing and index matching of tissue samples for high-resolution fluorescence imaging using SeeDB2 | |
Brady et al. | Assay of vesicle motility in squid axoplasm | |
CN109632420B (zh) | 一种基于水溶性试剂的快速组织透明化的处理方法及其应用 | |
Yu et al. | Translational rapid ultraviolet-excited sectioning tomography for whole-organ multicolor imaging with real-time molecular staining | |
CN113218741B (zh) | 组织透明化试剂盒和方法 | |
Summers et al. | Applications of confocal microscopy to studies of sea urchin embryogenesis | |
AU2018364670A1 (en) | Lipid-preserving refractive index matching for prolonged imaging depth for transparent tissue sample and composition | |
Tan et al. | Research Techniques Made Simple: Optical Clearing and Three-Dimensional Volumetric Imaging of Skin Biopsies | |
Tokanai et al. | An easy and rapid staining method for confocal microscopic observation and reconstruction of three‐dimensional images of echinoderm larvae and juveniles | |
Wainman | Expansion microscopy on Drosophila spermatocyte centrioles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230321 Address after: 200240 126 Wenxuan Medical Building, 800 Dongchuan Road, Minhang District, Shanghai Patentee after: Li Xiaowei Address before: 200240 No. 800, Dongchuan Road, Shanghai, Minhang District Patentee before: SHANGHAI JIAO TONG University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231207 Address after: 200233, Room 804, 8th Floor, Building 1, No. 315 Guiping Road, Xuhui District, Shanghai Patentee after: Shanghai Yifu Technology Co.,Ltd. Address before: 200240 126 Wenxuan Medical Building, 800 Dongchuan Road, Minhang District, Shanghai Patentee before: Li Xiaowei |
|
TR01 | Transfer of patent right |